Pharmaceutical and life-sciences occupiers require temperature-controlled, GDP-compliant (Good Distribution Practice) facilities — a specialist niche with limited speculative supply and high barriers to entry.
Yeats develops purpose-built pharmaceutical warehousing on long-let structures, typically 20–25 year leases with institutional-grade tenants. Pre-let agreements de-risk the development phase, while inflation-linked rent reviews provide investors with secure, index-linked income over the life of the asset.
The growth of UK life sciences, cold-chain distribution, and domestic pharmaceutical manufacturing continues to drive demand for compliant logistics space. Our construction expertise allows us to deliver the specialist M&E specification these occupiers require, while maintaining the cost discipline that protects development margins.
Key Characteristics
- Long secure income — typically 20 to 25 year leases with institutional tenants
- Pre-let structures de-risk development funding and exit
- Specialist specification creates high barriers to entry
- Strong GDV uplift versus standard industrial from secure, long-dated income
- GDP-compliant specification with temperature-controlled environments and full audit trail capability
